Broad Implementation of Outpatient Stewardship — BIOS  

Otitis Media Clinical Trial

Official title: Broad Implementation of Outpatient Stewardship (BIOS) Project

Status Active, not recruiting

Clinical Trial Summary

Reducing inappropriate antibiotic use is a key strategy to mitigate antibiotic resistance and adverse health effects associated with antibiotic exposure. The Broad Implementation of Outpatient Stewardship (BIOS) project focuses on broadly implementing an evidence-based intervention to improve antibiotic prescribing for acute respiratory tract infections in pediatric outpatient settings. Primary aims include: (1) examining the acceptability, feasibility and utility of a focused implementation strategy on improving intervention adoption and impact and (2) measuring the effectiveness of the intervention to reduce unnecessary broad-spectrum antibiotic prescription.

Clinical Trial Description

Antibiotics are commonly prescribed for acute respiratory tract infections (ARTIs) in pediatric outpatient settings, but up to half of antibiotic use is inappropriate. Prior work demonstrated broad-spectrum antibiotics did not improve patient health outcomes compared to narrow-spectrum antibiotics, but did increase harmful side effects. Overuse of broad-spectrum antibiotics can exacerbate antibiotic resistance and drug-related adverse events. Certain interventions have been effective in improving antibiotic prescribing, but none have been implemented widely. The BIOS project focuses on broadly implementing an evidence-based intervention to improve how clinicians in outpatient settings prescribe antibiotics for ARTIs in children 6 months to 12 years old. The intervention consists of educational modules and prescribing audit and feedback reports delivered to clinicians in a variety of outpatient settings across 5 health systems. Primary aims include: (1) examining the acceptability, feasibility and utility of a focused implementation strategy on improving intervention adoption and impact and (2) measuring the effectiveness of the intervention to reduce unnecessary broad-spectrum antibiotic prescription. Clinicians will be randomized to one of two arms: an early intervention arm or a delayed intervention (control) arm. The study will use a 4-period design, where the periods are as follows: Period 0: Baseline period that occurs prior to randomization Period 1: clinicians in the early intervention arm receive the intervention Period 2: All clinicians (both arms) receive the intervention Period 3: Maintenance period, external support from the study team is removed ;

Related Conditions & MeSH terms

• Acute Respiratory Tract Infection
• Acute Sinusitis
• Otitis Media
• Pharyngitis
• Respiratory Tract Infections
• Sinusitis

• NCT number: NCT05127161
• Study type: Interventional
• Source: Children's Hospital of Philadelphia
• Status: Active, not recruiting
• Phase: N/A
• Start date: October 31, 2022
• Completion date: April 21, 2025